(Q38034678)

27 August 2017

title

Direct effects of adipokines on the heart: focus on adiponectin (English)

1 reference

27 August 2017

Min Park

1

1 reference

27 August 2017

Gary Sweeney

series ordinal

2

1 reference

27 August 2017

publication date

1 September 2013

1 reference

27 August 2017

published in

Heart Failure Reviews

1 reference

27 August 2017

volume

18

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

631-644

1 reference

Metabolic syndrome and heart failure--the risk, paradox, and treatment

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

The obesity paradox in heart failure: accepting reality and making rational decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Cardiac remodeling in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Diabetic cardiomyopathy, causes and effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adipocytokines, cardiovascular pathophysiology and myocardial protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adipokines, myokines and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Novel biomarkers in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Modulation of the cardiovascular system by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Cardiovascular effects of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Apelin in acute myocardial infarction and heart failure induced by ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Serum resistin: physiology, pathophysiology and implications for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin and cardiovascular health: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin: a key player in obesity related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Cardioprotection by adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

APPL1: role in adiponectin signaling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin is synthesized and secreted by human and murine cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

AMP-activated protein kinase control of energy metabolism in the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Lipoprotein lipase mediated fatty acid delivery and its impact in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

APPL1 potentiates insulin secretion in pancreatic β cells by enhancing protein kinase Akt-dependent expression of SNARE proteins in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin-mediated modulation of hypertrophic signals in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

T-cadherin is critical for adiponectin-mediated cardioprotection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Markers of autophagy are downregulated in failing human heart after mechanical unloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Role of apoptosis in ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Cardiomyocyte death: mechanisms and translational implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

How and when do myocytes die during ischemia and reperfusion: the late phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Cardiomyocyte apoptosis in animal models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Inflammasomes in carcinogenesis and anticancer immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Eaten alive: a history of macroautophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

The regulation of autophagy - unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Tuning flux: autophagy as a target of heart disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Autophagy anomalies in the diabetic myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Cardiomyocyte autophagy: remodeling, repairing, and reconstructing the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Cardiac autophagy is a maladaptive response to hemodynamic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin supports cell survival in glucose deprivation through enhancement of autophagic response in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Regulation of autophagy in the heart: "you only live twice".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Is autophagy a double-edged sword for the heart?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Contribution of extracellular matrix to the mechanical properties of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Extracellular matrix remodeling during the progression of volume overload-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin and future coronary heart disease events among men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Association of adiponectin with left ventricular mass in blacks: the Jackson Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Serum adiponectin and coronary heart disease risk in older Black and White Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Circulating adiponectin concentrations in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin and left ventricular structure and function in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin and cardiac geometry and function in elderly: results from two community-based cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Differential impact of adipokines derived from primary adipocytes of wild-type versus streptozotocin-induced diabetic rats on glucose and fatty acid metabolism in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Leptin prevents the metabolic effects of adiponectin in L6 myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Antihypertrophic effects of adiponectin on cardiomyocytes are associated with the inhibition of heparin-binding epidermal growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin resistance and vascular dysfunction in the hyperlipidemic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Exercise training reverses adiponectin resistance in skeletal muscle of patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Functional adiponectin resistance and exercise intolerance in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Lipocalin-2/neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Iron overload cardiomyopathy: better understanding of an increasing disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Functional and mechanistic integration of infection and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

Adiponectin in chronic heart failure: influence of diabetes and genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

LAMP-2 Positive Vacuolar Myopathy with Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-012-9337-8

The ratio of serum leptin to adiponectin provides adjunctive information to the risk of metabolic syndrome beyond the homeostasis model assessment insulin resistance: the Korean Genomic Rural Cohort Study

21 January 2018

1 reference

12 December 2020

Role of adiponectin in the development of high fat diet-induced metabolic abnormalities in mice

1 reference

12 December 2020

Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes

1 reference

12 December 2020

Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort study

1 reference

12 December 2020

Does adiponectin resistance exist in chronic heart failure?

1 reference

12 December 2020

Adiponectin action: a combination of endocrine and autocrine/paracrine effects.

1 reference

12 December 2020

Adiponectin: sometimes good, sometimes bad?

1 reference

12 December 2020

Adiponectin resistance in heart failure and the emerging pattern of metabolic failure in chronic heart failure

1 reference

12 December 2020

Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress

1 reference

12 December 2020

Advances in echocardiography

1 reference

12 December 2020

Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha

1 reference

12 December 2020

Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Improved functional recovery to I/R injury in hearts from lipocalin-2 deficiency mice: restoration of mitochondrial function and phospholipids remodeling

1 reference

12 December 2020

Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice

1 reference

12 December 2020

Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway

1 reference

12 December 2020

Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography

1 reference

12 December 2020

Caspase-dependent protein phosphatase 2A activation contributes to endotoxin-induced cardiomyocyte contractile dysfunction*

1 reference

12 December 2020

10.1007/S10741-012-9337-8

Identifiers

DOI

1 reference

27 August 2017

1 reference